Dube Michael P Insider Trades & Stock Holdings

VP, Chief Accounting Officer · Intellia Therapeutics, Inc. · Latest filing Oct 2, 2026

Dube Michael P, VP, Chief Accounting Officer at Intellia Therapeutics, Inc. has 1 Form 4 trade on file since Oct 2, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($23.17K), net -$23.17K. Latest filing: disposed of 1.86K shares of $NTLA on Oct 2, 2026 at $12.43.

Trades on file

1

Open-market bought

$0

Open-market sold

$23.17K

Net open-market

-$23.17K

Latest filing

Oct 2, 2026

All insider trades by Dube Michael P

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$NTLA	Sell (Open-market sale)	1.86K	$12.43	$23.17K			+6.6%			VP, Chief Accounting Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Dube Michael P traded

• $NTLA

Frequently asked questions

Has Dube Michael P been buying or selling stock?

Dube Michael P has 0 open-market purchases and 1 open-market sale on file, net -$23.17K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Dube Michael P's latest insider trade?

disposed of 1.86K shares of $NTLA on Oct 2, 2026 at $12.43.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.